GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling Pathway
GSDMD plays an important role in the development of hypertensive nephropathy. Targeting GSDMD may be a therapeutic strategy for the treatment of hypertensive nephropathy.
Authors
- Bozhi Ye (ORCID: https://orcid.org/0000-0002-8713-0822)
- Zimin Fang
- Xianhui Lai
- Xiaoxi Fan (ORCID: https://orcid.org/0000-0003-2052-2757)
- Weijian Huang (ORCID: https://orcid.org/0000-0001-8417-7804)
- Yucong Zhang (ORCID: https://orcid.org/0000-0002-2991-5066)
- Shanshan Dai (ORCID: https://orcid.org/0000-0001-5124-5882)
- Bingjiang Han (ORCID: https://orcid.org/0000-0002-3916-5588)
- Rongqin Zheng (ORCID: https://orcid.org/0000-0002-7129-8436)
- Ji-Bo Han
- Wenli Zhang
Institutions
- Shanghai Jiao Tong University (CN)
- Wenzhou Medical University (CN)
- Ruijin Hospital (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Jiaxing University (CN)
- Yuxian People's Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/jir.s488553
- Citations
- 6
- Primary Topic
- Nitric Oxide and Endothelin Effects
- Type
- article
- Field-Weighted Citation Impact
- 1.96